Endurance Wealth Management’s C4 Therapeutics CCCC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | $15K | Hold |
1,850
| – | – | ﹤0.01% | 457 |
|
|
2023
Q1 | $0 | Hold |
1,850
| – | – | ﹤0.01% | 643 |
|
|
2022
Q4 | $11K | Hold |
1,850
| – | – | ﹤0.01% | 471 |
|
|
2022
Q3 | $16K | Hold |
1,850
| – | – | ﹤0.01% | 431 |
|
|
2022
Q2 | $14K | Buy |
1,850
+1,500
| +429% | +$11.4K | ﹤0.01% | 452 |
|
|
2022
Q1 | $8K | Hold |
350
| – | – | ﹤0.01% | 529 |
|
|
2021
Q4 | $11K | Hold |
350
| – | – | ﹤0.01% | 498 |
|
|
2021
Q3 | $12K | Hold |
350
| – | – | ﹤0.01% | 500 |
|
|
2021
Q2 | $15K | Hold |
350
| – | – | ﹤0.01% | 490 |
|
|
2021
Q1 | $13K | Buy |
+350
| New | +$13K | ﹤0.01% | 502 |
|